Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Decideum

Decideum has over 20 years experience in providing nuanced, effective and results-driven HTA and market access support to pharmaceutical clients in the UK and EU.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

- PMLiVE

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs

Sciterion Logo

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs

Company Details

Decideum
Niddry Lodge, 51 Holland Street, London, W8 7JB, United Kingdom
020 7368 1611
Contact Decideum
Website

 Latest Content from PMHub 

Love – it really does make the world go around

White Papers and Resources | February 12, 2020 | Page & Page Health

No two people are the same nor as individuals are we particularly predictable – we might like to think we are because at some point in time someone decided that...

OPEN Health supports Genetic Alliance UK’s Rare Film Festival!

White Papers and Resources | February 12, 2020 | OPEN Health

OPEN Health joined a number of rare disease patients, patient groups and industry representatives at the Regent Street cinema in London to see the winners announced at the Rare Film...

This isn’t goodbye, it’s see you in August!

Press Releases | February 12, 2020 | Bedrock Healthcare Communications

Bedrock Group imagines, creates and delivers industry-leading benefits

Courageous Conversations ep.2: What Our Healthcare System Can Learn from AlphaGo

Videos and Podcasts | February 11, 2020 | Impetus Digital

Courageous Conversations ep.1: Why Our Healthcare System is in Dire Need of Disruption

Videos and Podcasts | February 11, 2020 | Impetus Digital

Onyx Health receive national recognition as a “one to watch” business in Newcastle

Press Releases | February 10, 2020 | Onyx Health

Specialist marketing communications agency Onyx Health have been nationally recognised by The Sunday Times as one of six “one to watch” businesses based in Newcastle.

What is adult learning theory and how can it be used to help maximise your team’s potential?

White Papers and Resources | February 10, 2020 | OPEN Health

Written by Briony Frost, OPEN Health

Lighthouse Medical Communications US – An opportunity of a lifetime to be part of the Lucid Group magic

Videos and Podcasts | February 6, 2020 | Lucid Group Communications Limited

Our family at Lighthouse Medical Communications US are looking for talented individuals to join its team in hashtagManhattan. If you want to be part of something magical get in touch...

Blueberry Therapeutics receives clearance from the FDA to proceed with the clinical investigation of BB2603

Press Releases | February 3, 2020 | Onyx Health

Blueberry Therapeutics has received an investigational new drug (IND) clearance from the Food and Drug Administration (FDA) to proceed with the clinical development of BB2603

Empowering and equipping medical affairs teams to embrace an ever-expanding remit

White Papers and Resources | February 3, 2020 | OPEN Health

Written by Jess Ingram and Francisca Costa, OPEN Health